Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation

Journal of Leukocyte Biology

Volumn 88, Issue 1, 2010, Pages 159-168

  Redente, Elizabeth F ^a   Higgins, David M ^b   Dwyer Nield, Lori D ^a   Orme, Ian M ^b   Gonzalez Juarrero, Mercedes ^b   Malkinson, Alvin M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Butylated hydroxytoluene; IFN ; IL 4; Tuberculosis

Indexed keywords

ARGINASE 1; BUTYLCRESOL; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL COMPOSITION; CELL POLARITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; FEMALE; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; LUNG LAVAGE; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MALE; MONOCYTE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHRONIC DISEASE; CYTOLOGY; IMMUNOLOGY; PHYSIOLOGY;

MUS; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; BONE MARROW CELLS; BUTYLATED HYDROXYTOLUENE; CELL POLARITY; CHRONIC DISEASE; INTERFERON-GAMMA; INTERLEUKIN-4; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; PNEUMONIA; TUBERCULOSIS;

EID: 77954682669     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0609378     Document Type: Article

References (50)

1. Kobzik, L., Bredt, D. S., Lowenstein, C. J., Drazen, J., Gaston, B., Sugarbaker, D., Stamler, J. S. (1993) Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol. 9, 371-377.
2. American Lung Association (2006) Lung Disease Data: 2006. lungusa.org, 1-97.
3. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., Hill, A. M. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
4. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
5. Stout, R. D., Suttles, J. (2005) Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol. Rev. 205, 60-71.
6. Kaminski, N. (2003) Microarray analysis of idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 29, S32-S36.
7. Kunkel, S. L., Chensue, S. W., Lukacs, N., Hogaboam, C. (2003) Cytokine phenotypes serve as a paradigms for experimental immune-mediated lung diseases and remodeling. Am. J. Respir. Cell Mol. Biol. 29, S63-S66.
8. Redente, E. F., Orlicky, D. J., Bouchard, R. J., Malkinson, A. M. (2007) Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice. Am. J. Pathol. 170, 693-708.
9. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686. (Pubitemid 39457982)
10. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349. (Pubitemid 40884337)
11. Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., Klemke, C. D., Dippel, E., Kodelja, V., Orfanos, C. E. (1999) Alternative versus classical activation of macrophages. Pathobiology 67, 222-226. (Pubitemid 30135909)
12. Mantovani, A., Allavena, P., Sozzani, S., Vecchi, A., Locati, M., Sica, A. (2004) Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin. Cancer Biol. 14, 155-160.
13. Marino, A. A., Mitchell, J. T. (1972) Lung damage in mice following intraperitoneal injection of butylated hydroxytoluene. Proc. Soc. Exp. Biol. Med. 140, 122-125.
14. Adamson, I. Y., Bowden, D. H., Cote, M. G., Witschi, H. (1977) Lung injury induced by butylated hydroxytoluene: cytodynamic and biochemical studies in mice. Lab. Invest. 36, 26-32.
15. Malkinson, A. M. (1979) Prevention of butylated hydroxytoluene-induced lung damage in mice by cedar terpene administration. Toxicol. Appl. Pharmacol. 49, 551-560.
16. Witschi, H., Malkinson, A. M., Thompson, J. A. (1993) Metabolism and pulmonary toxicity of butylated hydroxytoluene. In Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells (T. E. Gram, ed.), Tarrytown, NY, USA, Pergamon, 185-212.
17. Bauer, A. K., Dwyer-Nield, L. D., Keil, K., Koski, K., Malkinson, A. M. (2001) Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion. Exp. Lung Res. 27, 197-216.
18. Miller, A. C., Dwyer, L. D., Auerbach, C. E., Miley, F. B., Dinsdale, D., Malkinson, A. M. (1994) Strain-related differences in the pneumotoxic effects of chronically administered butylated hydroxytoluene on protein kinase C and calpain. Toxicology 90, 141-159.
19. Thompson, J. A., Schullek, K. M., Fernandez, C. A., Malkinson, A. M. (1989) A metabolite of butylated hydroxytoluene with potent tumor-promoting activity in mouse lung. Carcinogenesis 10, 773-775.
20. Bauer, A. K., Dwyer-Nield, L. D., Hankin, J. A., Murphy, R. C., Malkinson, A. M. (2001) The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice. Toxicology 169, 1-15.
21. Dharmadhikari, A. S., Nardell, E. A. (2008) What animal models teach humans about tuberculosis. Am. J. Respir. Cell Mol. Biol. 39, 503-508.
22. Schluger, N. W., Rom, W. N. (1998) The host immune response to tuberculosis. Am. J. Respir. Crit. Care Med. 157, 679-691.
23. Dannenberg, A. M. (1992) Pathophysiology: basic aspects. In Tuberculosis and Nontuberculosis Mycobacterial Infections (D. Schlossberg, ed.), Philadelphia, PA, USA, W.B. Saunders Co., 17-47.
24. Cox, J. S., Chen, B., McNeil, M., Jacobs Jr., W. R. (1999) Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402, 79-83.
25. Higgins, D. M., Sanchez-Campillo, J., Rosas-Taraco, A. G., Higgins, J. R., Lee, E. J., Orme, I. M., Gonzalez-Juarrero, M. (2008) Relative levels of M-CSF and GM-CSF influence the specific generation of macrophage populations during infection with Mycobacterium tuberculosis. J. Immunol. 180, 4892-4900.
26. Gonzalez-Juarrero, M., Hattle, J. M., Izzo, A., Junqueira-Kipnis, A. P., Shim, T. S., Trapnell, B. C., Cooper, A. M., Orme, I. M. (2005) Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukoc. Biol. 77, 914-922.
27. Rhoades, E. R., Frank, A. A., Orme, I. M. (1997) Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78, 57-66.
28. Orme, I. M. (1998) The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol. 6, 94-97.
29. Turgeon, M. L. (1999) Hematopoiesis. Clinical Hematology: Theory and Procedures. Philadelphia, PA, USA, Lippincott Williams and Wilkins, 49-57.
30. Adams, L. B., Mason, C. M., Kolls, J. K., Scollard, D., Krahenbuhl, J. L., Nelson, S. (1995) Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. J. Infect. Dis. 171, 400-405.
31. Orme, I. M., Collins, F. M. (1994) Mouse model of tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control (B. R. Bloom, ed.), Washington, DC, USA, ASM, 113-133.
32. Orme, I. M., Roberts, A. D., Griffin, J. P., Abrams, J. S. (1993) Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151, 518-525.
33. D'Ambrosio, D., Mariani, M., Panina-Bordignon, P., Sinigaglia, F. (2001) Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am. J. Respir. Crit. Care Med. 164, 1266-1275.
34. Hussell, T., Isaacson, P. G., Crabtree, J. E., Spencer, J. (1996) Helicobacter pylori-specific tumor-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J. Pathol. 178, 122-127.
35. Greiner, A., Knorr, C., Qin, Y., Schultz, A., Marx, A., Kroczek, R. A., Muller-Hermelink, H. K. (1998) CD40 ligand and autoantigen are involved in the pathogenesis of low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Dev. Immunol. 6, 187-195.
36. Cortijo, J., Sanz, M. J., Iranzo, A., Montesinos, J. L., Nabah, Y. N., Alfon, J., Gomez, L. A., Merlos, M., Morcillo, E. J. (2006) A small molecule, orally active, α4β1/α4β7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats. Br. J. Pharmacol. 147, 661-670.
37. Davis, J. M., Ramakrishnan, L. (2009) The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49.
38. Ordway, D., Harton, M., Henao-Tamayo, M., Montoya, R., Orme, I. M., Gonzalez-Juarrero, M. (2006) Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis. J. Immunol. 176, 4931-4939.
39. D'Souza, C. D., Cooper, A. M., Frank, A. A., Ehlers, S., Turner, J., Bendelac, A., Orme, I. M. (2000) A novel nonclassic β2-microglobulin- restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am. J. Respir. Cell Mol. Biol. 23, 188-193.
40. Ly, L. H., Russell, M. I., McMurray, D. N. (2007) Microdissection of the cytokine milieu of pulmonary granulomas from tuberculous guinea pigs. Cell. Microbiol. 9, 1127-1136.
41. Hernández-Pando, R., Orozco-Esteves, H., Maldonado, H. A., Aguilar-León, D., Vilchis-Landeros, M. M., Mata-Espinosa, D. A., Mendoza, V., López-Casillas, F. (2006) A combination of a transforming growth factor-β antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis. Clin. Exp. Immunol. 144, 264-272.
42. Takeuchi, M., Alard, P., Streilein, J. W. (1998) TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160, 1589-1597. (Pubitemid 28106442)
43. Wynn, T. A. (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4, 583-594.
44. Holscher, C., Arendse, B., Schwegmann, A., Myburgh, E., Brombacher, F. (2006) Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice. J. Immunol. 176, 1115-1121. (Pubitemid 43099713)
45. Herbert, D. R., Holscher, C., Mohrs, M., Arendse, B., Schwegmann, A., Radwanska, M., Leeto, M., Kirsch, R., Hall, P., Mossmann, H., Claussen, B., Forster, I., Brombacher, F. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20, 623-635. (Pubitemid 38659504)
46. Joshi, A. D., Raymond, T., Coelho, A. L., Kunkel, S. L., Hogaboam, C. M. (2008) A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone-marrow-derived macrophages to Toll-like receptor agonists. J. Leukoc. Biol. 83, 314-324.
47. Redente, E. F., Dwyer-Nield, L. D., Merrick, D. T., Raina, K., Agarwal, R., Pao, W., Rice, P. L., Shroyer, K. R., Malkinson, A. M. (2010) Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization. Am. J. Pathol., In press.
48. Auffray, C., Sieweke, M. H., Geissmann, F. (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692.
49. Krishnamurthy, S., Yadav, S. (2007) Immune thrombocytopenic purpura as a presentation of childhood tuberculosis. Indian J. Pediatr. 74, 853-855.
50. Talbot, S., Dowling, A., Dowling, J. P., Fuller, A., Schwarz, M. (1998) Mediastinal nodal tuberculosis presenting as immune thrombocytopenia. Aust. N. Z. J. Med. 28, 465-466.